Announcement
September 14, 2021
Boston Molecules has finalized the configuration of its ZyaltTM COVID-19 IgM&IgG DR TEST kit, and will commence scaled up production
Antibody
Boston MoleculesTM is a leading custom antibody developer facilitated with cutting edge technologies and innovations. Our B-cell cloning antibody platform is emerging as the world’s best monoclonal antibody development strategy that outperformed traditional hybridoma technologies by more than 10 fold increase of positive colony numbers and superior affinities in selected antibodies.
Cohesive with our Bioinformatics scientists and Crystallography scientists, our custom antibody services deliver >90% successful projects by guaranteed antibody development strategies including antigen 3D structure prediction and homologous sequence exclusions. We also offer 60-70 days short turnaround cost-efficient polyclonal antibody services with free epitobe prediction service.
SERVICE FEATURES
- Cutting edge B-Cell cloning technologies
- >95% successful rate
- Guaranteed packages
- Western blot guaranteed packages
- Elisa guaranteed packages
- IHC guaranteed packages
- IP guaranteed packages
- Fast turnaround (60-70 days delivery of polyclonal antibody)
Quotations: Get an instant quote
Protien Services from BM
September 14, 2021
Boston Molecules developed a novel mammalian protein platform (Z-ActiveTM) using chaperone-assisted protein expression technology to express super active cytokines and
Antibody Services
August 24, 2021
Boston MoleculesTM is a leading custom antibody developer facilitated with cutting edge technologies and innovations. Our B-cell cloning antibody platform